Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prostaglandin Analogs in Thyroid Eye Disease
NCT01927406Phase 4Withdrawn
- Sponsor
- Stanford University
- Start
- Jun 2014
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bimatoprost in thyroid eye disease (TED), sponsored by Stanford University. Planned start Jun 2014; status: withdrawn.
02
Drugs
bimatoprost
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT01927406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01927406.